期刊
CELLS
卷 11, 期 20, 页码 -出版社
MDPI
DOI: 10.3390/cells11203200
关键词
non-small-cell lung cancer; targeted therapies; immunotherapies
类别
资金
- Chengdu University of Traditional Chinese Medicine [YYZX2020093]
This review summarizes the current and potential therapies for non-small-cell lung cancer (NSCLC), with a focus on targeted therapies and immunotherapies. It highlights the future role of metabolic therapies and combination therapies in NSCLC.
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies and the leading causes of cancer-related death worldwide. Despite many therapeutic advances in the past decade, NSCLC remains an incurable disease for the majority of patients. Molecular targeted therapies and immunotherapies have significantly improved the prognosis of NSCLC. However, the vast majority of advanced NSCLC develop resistance to current therapies and eventually progress. In this review, we discuss current and potential therapies for NSCLC, focusing on targeted therapies and immunotherapies. We highlight the future role of metabolic therapies and combination therapies in NSCLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据